Jennie Lill

Jennie Lill

Company: Genentech

Job title: Senior Director of Proteomics & NGS


Engineered T cells for the Treatment of Malignancy 11:40 am

Challenges with current therapeutic modalities, and why engineered T cell therapeutics are an attractive option. Challenges and improvements to in silico based prediction methods for selecting epitopes for generating TCRs against. Current strategy for selecting epitopes for engineering T cells against using a combination of biochemical and mass spectrometric approaches.Read more

day: Focus Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.